Clinical Trials Begin For Locally Developed Covid-19 Vaccines In Nigeria

 Clinical Trials Begin For Locally Developed Covid-19 Vaccines In Nigeria

Nigeria has begun clinical trials for the two locally developed covid-19 vaccines.

The announcement was made public by the chairman of the presidential task force on covid-19, Boss Mustapha.

Mustapha told reporters last week that the vaccines will be ready for use after relevant certifications have been obtained at the completion of rounds of trials.

The Covid-19 vaccines were developed by Nigerian scientists, and described as a scientific breakthrough that will ‘’ boost the morale and image of the medical industry in the country’’.

So far Nigeria has taken delivery of 4 million doses of the Oxford-Astrazeneca vaccines from the Covax initiative. The country plans to receive 16 million doses.

Earlier this year, the Federal government announced that it had pumped some $25 million to develop local vaccines to battle the coronavirus and according to Mustapha, the vaccine development is proof that the government is working.

Currently, Nigeria has recorded 163,000 coronvarius cases, 152,000 have recovered and some 2,058 covid-19 related deaths have been registered.

Patsy Nwogu

A writer focused on data journalism, health and data analytics.

Related post